Position in INFU
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,258,157
+$223,419 QoQ
Shares Held
130,379
+16.3% QoQ
Ownership
0.655%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 98 holders
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in INFU Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Man Group plc holds $533,295,768 across 39 Medical Devices names. INFU ranks #23 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
3,225,164 | $137,649,998 | |
| 2 | EW |
Edwards Lifesciences Corp
|
935,186 | $84,596,924 | |
| 3 | PODD |
Insulet Corp
|
517,217 | $78,746,287 | |
| 4 | ABT |
Abbott Laboratories
|
800,719 | $72,657,242 | |
| 5 | MDT |
Medtronic plc
|
416,155 | $32,555,805 | |
| 6 | DXCM |
Dexcom Inc
|
394,449 | $26,566,138 | |
| 7 | PEN |
Penumbra Inc
|
80,224 | $25,330,727 | |
| 8 | STE |
STERIS plc
|
99,334 | $20,916,760 |
All Filings in INFU
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,258,157 | 130,379 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,034,738 | 112,106 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $477,168 | 53,196 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $458,916 | 44,297 | Shares | Defined | 2025-11-14 | |
| 2023-06-30 | $153,877 | 15,979 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $200,647 | 25,890 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $210,532 | 24,255 | Shares | Defined | 2023-02-14 | |
| 2021-12-31 | $214,578 | 12,600 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 | $234,587 | 11,522 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||